Search results

Retrieving an Antarctic ice core more than a million years old presents challenges and opportunities.

Over the last decades, neutron, photon, and ion beams have been established as an innovative and attractive investigative approach to characterise cultural-heritage materials.

State- of-the-art microdosimeters used in research

An international team led by scientists at City University of Hong Kong has found flexible metal-organic framework (MOF) with one-dimensional channels that acts as a “molecular trapdoor” to selectively adsorb gases, such as carbon dioxide, in response to temperature and pressure changes.

Australian and New Zealand Society of Nuclear Medicine recognises Nigel Lengkeek

Australia launched a new international development project in partnership with the International Atomic Energy Agency (IAEA) to advance ‘Rays of Hope’ in the Asia and Pacific region. 

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

Research collaboration with University of Sydney focuses on a personalised approach to cancer treatment.

Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub

2025 ANSTO Work Experience Program will be open for applications in the new year.

ANSTO is interested finding students to collaborate on Generation IV reactor systems.

Lutetium-177 used for advanced prostate cancer

Cosmogenic nuclides measurements at ANSTO to be part of large international Antarctic glacier research.

The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.